EKEsra Gizem Koyuncu

Esra Gizem Koyuncu

*This is an algorithmically generated author record based on publicly available information.

Esra Gizem Koyuncu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Factors affecting distal femoral cartilage in healthy adolescents: a cross-sectional ultrasonographic study

    by Pınar Özge Avar Aydın, Esra Gizem Koyuncu, Nuray Arda, Levent Özçakar

    Background. Distal femoral cartilage is the most commonly deteriorated articular cartilage during metabolic and inflammatory processes. Musculoskeletal ultrasound (MSUS) is a widely accessible imaging modality to assess distal femoral cartilage thickness (DFCT). This study aims to explore DFCT and associated factors in healthy adolescents. Methods. Healthy adolescents aged between 12-18 years were eligible for the study. The central points of the medial and lateral femoral condyles and the intercondylar area were measured on bilateral knees by using B-mode MSUS according to a predefined scanning protocol. The average of DFCT measurements was evaluated according to age, sex, anthropometric measurements, exercise habits, and vitamin D levels. Results. A total of 150 adolescents participated in the study, with a mean age of 15 year; 67% were female. Age and sex were two factors showing significant effects on mean DFCT (p≤0.001). A negative mild correlation was observed between age and mean DFCT (r=-0.252, p=0.002). Weight, height, body mass index, and exercise frequency were not related to DFCT. Participants with severe vitamin D deficiency had similar DFCT when compared with others, and no correlation was observed between their levels (r=0.109, p=0.191). Conclusion. DFCT varies during adolescence, with age and sex identified as the primary associated factors. Anthropometric measurements, exercise frequency, and vitamin D levels did not show any effect on DFCT in healthy adolescents.

  • Open Access

    Frequency of fibromyalgianess in patients with rheumatoid arthritis and ankylosing spondylitis: A multicenter study of Turkish League Against Rheumatism (TLAR) network

    by Fikriye Figen Ayhan, Ayşen Akıncı, İlKer Ünal, Ömer Faruk Şendur, Elif Aydın, Esra Gizem Koyuncu, Nurettin Taştekin, Akın Erdal, Ülkü Uçar, Taciser Kaya, et al.

    Objectives: This study aimed to evaluate the frequency of fibromyalgianess, fibromyalgia syndrome (FS), and widespread pain in patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and their relationship with clinical and demographic parameters. Patients and methods: This cross-sectional multicenter trial was performed in 14 centers across Türkiye between June 2018 and November 2019. Out of 685 patients recruited from the accessible population, 661 patients (342 RA, 319 AS; 264 males, 397 females; mean age: 48.1±12.9 years; range, 17 to 88 years) met the selection criteria. In these cohorts, those who did not meet the criteria for FS and had widespread pain (widespread pain index ≥7) were evaluated as a separate group. Clinical status and demographic parameters of patients in both cohorts were evaluated as well as the evaluations of RA and AS patients with widespread pain (widespread pain index ≥7) and RA and AS patients with FS groups. In addition, correlations between polysymptomatic distress scale (PSD) scores and Visual Analog Scale (VAS), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and Disease Activity Score using 28 joint counts for RA patients and VAS, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Ankylosing Spondylitis Disease Activity Score (ASDAS) for AS patients were analyzed. Results: Frequencies of patients with FS and patients who had PSD scores ≥12 were 34.1% and 44.4% in all RA patients, respectively. Moreover, FS and PSD scores ≥12 were found in 29.2% and 36.9% of all AS patients, respectively. PSD scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. SDAI and CDAI scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. Similarly, PSD scores of AS patients with FS were higher than all AS patients and AS patients with widespread pain. ASDAS-erythrocyte sedimentation rate and BASDAI scores of AS patients with FS were found higher than all AS patients and AS patients with widespread pain. Conclusion: Disease activity scores, including pain in RA and AS, were higher in the presence of FS or fibromyalgianess. It may be related to clinical parameters, but cohort studies with long-term follow-up are needed to reveal causality. Additionally, to avoid overtreatment, coexistence of fibromyalgianess should be kept in mind in patients who have inflammatory diseases such as RA and AS, particularly with intractable widespread pain.


  • Open Access

    Successful Resolution of Pachydermodactyly in an Adolescent Boy

    by Pınar Özge Avar-Aydın, Esra Gizem Koyuncu, İsMet Aşıkhasan

    Cite this article as: Avar-Aydın PÖ, Koyuncu EG, Aşıkhasan İ. Successful resolution of pachydermodactyly in an adolescent boy. Turk Arch Pediatr. 2024;59(3):328-329.


  • The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Bioimpedance Spectroscopy and Circumferential Measurements

    by Pınar Borman, Ayşegül Yaman, Lütfi Doğan, Ayşe Arıkan Dönmez, Esra Gizem Koyuncu, Ayşegül Balcan, Sercan Aksoy, Cihangir Özaslan, Rabiye Akın, Kaniye Üneş

    The survival of patients with breast cancer has prolonged due to early diagnosis and modern methods of treatment and lymphedema has become the most important morbidity secondary to the treatment of the disease. Early detection and timely intervention have potential to reduce advanced breast cancer-related lymphedema. The aims of this study were to comparatively determine the frequency of subclinical/clinical lymphedema by using prospective monitoring with bioimpedance spectroscopy (BIS) and circumferential measurements in a group of patients who underwent breast cancer surgery. Patients having breast cancer surgery were recruited between October 2018 and December 2019. Demographical and surgical properties were recorded. Extremity volumes by circumferential and BIS measurements were performed after surgery (baseline) and monitorizations were carried out at third and sixth months, in order to determine the frequency of subclinical/clinical lymphedema. L-Dex value of >6.5 was recently taken attention as subclinical lymphedema and values >7 were considered as clinical lymphedema. The presence of subclinical and clinic lymphedema was assessed by inter-limb volume difference (>5% and >10 respectively) based on the serial circumferential measurements in both affected and non-affected extremities. The functional status and quality of Life (QoL) were determined by quick-DASH and LYMQOL-Arm questionnaires respectively. The relationship between volume measurements, functional status and QoL scores were determined. Eighty-two female patients with a mean age of 49.6 years were included to the study. 30 (36.5%) and 21 (25.6%) of patients were determined as having subclinical/clinical lymphedema by BIS, while 18 (21.9%) and 19 (23.1%) of patients had subclinical/clinical lymphedema by circumferentialmeasurements at third-and-sixth months respectively. The functional and QoL scores were not correlated with circumferential volume measurements and BIS scores. There was a moderate-high correlation with BIS and circumferential measurements. In conclusion 36.5% and 25.6% of our study group had subclinical and clinical lymphedema by BIS respectively during the 6 months surveillance period. Periodic monitoring of women with BIS allows early detection for lymphedema in more patients than in circumferential volume measurements, which may have implications for timely and necessary management.


  • Reassessing Sarcopenia in Hypertension: STAR and ACE Inhibitors Excel

    by Ayşe Merve Ata, Murat Kara, Timur Ekiz, Özgür Kara, Mehmet Ali Culha, Vincenzo Ricci, Esra Gizem Koyuncu, Fırat Özcan, Bayram Kaymak, Levent Özçakar

    Background Hypertension and sarcopenia are commonly seen in older adults. The renin‐angiotensin system and the therapeutic use of angiotensin converting enzyme (ACE) inhibitors have been on the agenda of sarcopenia in different perspectives. Our aim was to explore the frequency of sarcopenia in patients with hypertension and to investigate the association between the use of ACE inhibitors and sarcopenia. Methods A total of 272 community dwelling adults were recruited. Anterior thigh muscle thickness was measured by ultrasound. Handgrip strength, gait speed and chair stand test were evaluated. Low muscle mass was diagnosed in the presence of low sonographic thigh adjustment ratio (STAR) values and sarcopenia was diagnosed if low STAR values were coupled with low functional tests. Results 136 subjects (50.0%) had no comorbid disease; 102 (37.5%) had one, 21 (7.7%) had two, nine (3.3%) had three and four (1.5%) had four comorbid diseases. Both low muscle mass (41.9% vs. 13.2%) and sarcopenia (32.2% vs. 7.8%) were more commonly seen in hypertensive when compared to normotensive older adults. Subgroup analysis of older adults with hypertension revealed that sarcopenia was less prevalent (p=0.003) in patients using ACE inhibitors (8.7%) than those using angiotensin receptor blockers (48.7%) and other antihypertensive drugs (46.4%). After binary logistic regression analyses; only the presence of hypertension seemed to independently predict the development of sarcopenia in older adults [OR=6.5 (95% CI: 2.4‐17.8, p<0.001)]. Conclusions Sarcopenia is highly prevalent in hypertensive older adults. Among many antihypertensive medications, ACE inhibitors seem to have favorable effects on both disorders.